Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Change in Accured Expenses (2023 - 2025)

Bioregenx has reported Change in Accured Expenses over the past 3 years, most recently at $53771.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 47.68% year-over-year to $53771.0; the TTM value through Dec 2025 reached -$18590.0, down 131.15%, while the annual FY2025 figure was -$18590.0, 131.15% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was $53771.0 at Bioregenx, up from -$24896.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $94924.0 in Q2 2023 and troughed at -$136984.0 in Q4 2023.
  • A 3-year average of $4018.8 and a median of $29022.0 in 2023 define the central range for Change in Accured Expenses.
  • On a YoY basis, Change in Accured Expenses climbed as much as 251.04% in 2025 and fell as far as 406.31% in 2025.
  • Year by year, Change in Accured Expenses stood at -$136984.0 in 2023, then surged by 126.58% to $36410.0 in 2024, then soared by 47.68% to $53771.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for BRGX at $53771.0 in Q4 2025, -$24896.0 in Q3 2025, and -$109036.0 in Q2 2025.